[Osteomalacia: new aspects of pathogenesis and treatment].
D002118:Calcium / Q000627:therapeutic use; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D006961:Hyperparathyroidism / Q000150:complications; D010018:Osteomalacia / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D010634:Phenobarbital / Q000009:adverse effects; D010758:Phosphorus / Q000378:metabolism / Q000627:therapeutic use; D012279:Rickets / Q000209:etiology; D013997:Time Factors; D014807:Vitamin D / Q000627:therapeutic use; D014808:Vitamin D Deficiency / Q000150:complications
D006827:Hydantoins; D014807:Vitamin D; D010758:Phosphorus; D002118:Calcium; D010634:Phenobarbital
Ostéomalacie: nouveaux aspects de la pathogénése et du traitement.